210 related articles for article (PubMed ID: 27825534)
1. Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain).
Nuño-Solinís R; Alonso-Morán E; Arteagoitia Axpe JM; Ezkurra Loiola P; Orueta JF; Gaztambide S
Endocrinol Nutr; 2016 Dec; 63(10):543-550. PubMed ID: 27825534
[TBL] [Abstract][Full Text] [Related]
2. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and costs of multimorbidity by deprivation levels in the basque country: a population based study using health administrative databases.
Orueta JF; García-Álvarez A; García-Goñi M; Paolucci F; Nuño-Solinís R
PLoS One; 2014; 9(2):e89787. PubMed ID: 24587035
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic characteristics associated with type 2 diabetes.
Sicras-Mainar A; Navarro-Artieda R; Ibáñez-Nolla J
Rev Clin Esp (Barc); 2014 Apr; 214(3):121-30. PubMed ID: 24359793
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of depression in adults with type 2 diabetes in the Basque Country: relationship with glycaemic control and health care costs.
Alonso-Morán E; Satylganova A; Orueta JF; Nuño-Solinis R
BMC Public Health; 2014 Jul; 14():769. PubMed ID: 25073532
[TBL] [Abstract][Full Text] [Related]
6. Healthcare Burden and Costs Associated with Urinary Tract Infections in Type 2 Diabetes Mellitus Patients: An Analysis Based on a Large Sample of 456,586 German Patients.
Wilke T; Böttger B; Berg B; Groth A; Botteman M; Yu S; Fuchs A; Maywald U
Nephron; 2016; 132(3):215-26. PubMed ID: 26930608
[TBL] [Abstract][Full Text] [Related]
7. Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis.
Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
J Med Econ; 2016 Jul; 19(7):655-62. PubMed ID: 26855139
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes mellitus in China: a preventable economic burden.
Wang W; McGreevey WP; Fu C; Zhan S; Luan R; Chen W; Xu B
Am J Manag Care; 2009 Sep; 15(9):593-601. PubMed ID: 19747024
[TBL] [Abstract][Full Text] [Related]
9. Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus.
Sicras-Mainar A; Navarro-Artieda R; Morano R; Ruíz L
Endocrinol Nutr; 2016 Dec; 63(10):527-535. PubMed ID: 27744013
[TBL] [Abstract][Full Text] [Related]
10. Incidence of severe hypoglycaemic episodes in patients with type 2 diabetes in the Basque country: impact on healthcare costs.
Alonso-Morán E; Orueta JF; Nuño-Solinís R
BMC Health Serv Res; 2015 May; 15():207. PubMed ID: 26012499
[TBL] [Abstract][Full Text] [Related]
11. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
[TBL] [Abstract][Full Text] [Related]
12. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania.
Domeikienė A; Vaivadaitė J; Ivanauskienė R; Padaiga Ž
Medicina (Kaunas); 2014; 50(1):54-60. PubMed ID: 25060205
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the economic and health impact of complications of type 2 diabetes mellitus in the autonomous community of Madrid (Spain).
Arrieta F; Rubio-Terrés C; Rubio-Rodríguez D; Magaña A; Piñera M; Iglesias P; Nogales P; Calañas A; Novella B; Botella-Carretero JI; Debán C; Zamarrón I; Mora G; Balsa JA; Vázquez C;
Endocrinol Nutr; 2014 Apr; 61(4):193-201. PubMed ID: 24440211
[TBL] [Abstract][Full Text] [Related]
14. How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China.
Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
BMJ Open; 2018 Nov; 8(11):e020647. PubMed ID: 30389755
[TBL] [Abstract][Full Text] [Related]
15. Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review.
Einarson TR; Acs A; Ludwig C; Panton UH
Value Health; 2018 Jul; 21(7):881-890. PubMed ID: 30005761
[TBL] [Abstract][Full Text] [Related]
16. Multimorbidity in people with type 2 diabetes in the Basque Country (Spain): Prevalence, comorbidity clusters and comparison with other chronic patients.
Alonso-Morán E; Orueta JF; Esteban JI; Axpe JM; González ML; Polanco NT; Loiola PE; Gaztambide S; Nuño-Solinís R
Eur J Intern Med; 2015 Apr; 26(3):197-202. PubMed ID: 25701236
[TBL] [Abstract][Full Text] [Related]
17. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of healthcare utilisation and expenditure in people with type 2 diabetes mellitus with and without major depressive disorder.
Huang CJ; Lin CH; Hsieh HM; Chang CC; Chu CC; Sun DP; Weng SF
Gen Hosp Psychiatry; 2019; 57():50-58. PubMed ID: 30908962
[TBL] [Abstract][Full Text] [Related]
19. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.
Mata-Cases M; Casajuana M; Franch-Nadal J; Casellas A; Castell C; Vinagre I; Mauricio D; Bolíbar B
Eur J Health Econ; 2016 Nov; 17(8):1001-1010. PubMed ID: 26542160
[TBL] [Abstract][Full Text] [Related]
20. Cost analysis of type 2 diabetes mellitus treatment in economically developed countries.
Ramzan S; Timmins P; Hasan SS; Babar ZU
Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):5-14. PubMed ID: 30146917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
